NCT03905603View on ClinicalTrials.gov

Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

October 8, 2019

Primary Completion Date

April 1, 2026

Study Completion Date

May 1, 2026

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

ACTH

ACTH (Cosyntropin) 250 mcg will be given once during the study.

DRUG

rhCG

rhCG (Ovidrel) 250 mcg will be given once during the study.

Trial Locations (1)

22901

RECRUITING

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER